Description

ATAC21, a linker-immune-stimulatory compound that can be formed by conjugating a noncleavable maleimide-PEG4 linker containing a succinimide group with an immune- stimulatory compound. ATAC21 can be combined with SBT-040 (anti-CD40 antibody) to form a conjugate[1].–Applications–Formula-C38H50N12O21P2-Citation–References-[1]Peter Armstrong Thompson, et al. Tumor targeting conjugates and methods of use thereof. WO2018140831A2.-CASNumber-2101204-23-1-MolecularWeight-1072.82-Compound Purity–SMILES-O[C@H]1[C@@H](O[C@@]2([H])[C@@]1([H])OP(O)(OC[C@]3([H])[C@@]([C@H]([C@H](N4C5=C(C(N=C(N5)N)=O)N=C4)O3)O)([H])OP(O)(OC2)=O)=O)N6C7=NC=NC(NC(CCOCCOCCOCCOCCNC(CCN8C(C=CC8=O)=O)=O)=O)=C7N=C6-Research_Area-Cancer-Solubility-10 mM in DMSO-Target-Drug-Linker Conjugates for ADC-Isoform–Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related